INDEX 841
moxifloxacin, 797
MRIseemagnetic resonance imaging
MRSAseemethicillin-resistantStaphylococcus aureus
MRSPseemethicillin-resistantStaphylococcus
pseudintermedius
MRSSseemethicillin-resistantStaphylococcus schleiferi
MTXseemethotrexate
mucinosis
cutaneous (secondary), 615, 617, 619, 621, 622,
624, 627
defined, 40
mucocutaneous pyoderma (MCP), 213, 214, 222
nasal planum, 67, 140
mucous membrane cutaneous lupus erythematosus
(MCLE), 468, 469–470, 471, 476
mucous membrane pemphigoid
clinical features, 63, 191, 208
etiology/pathophysiology, 189
see alsopemphigoid complex
Munro’s microabscess, 40
mupirocin ointment, 151, 159, 164, 550
muscle biopsy, 314
muzzle folliculitis/furunculosis, 157, 213
see alsoacne
mycobacterial infections, 510–517
clinical features, 512–513,517–520
diagnostics, 513–514
differential diagnosis, 513
etiology/pathophysiology, 510–511
signalment/history, 511–512
therapeutics, 515–516
zoonotic potential, 517
mycobacterial panniculitis, 511, 512, 513,519–520
mycobacteriosis
feline multisystemic granulomatous, 513
systemic nontuberculous (atypical), 511
clinical features, 63,119,513,519–520
diagnostics, 514
prognosis, 516
signalment/history, 512
treatment, 515, 516
Mycobacterium aviumcomplex, 510, 511, 515
Mycobacterium bovis, 510, 511, 515
Mycobacterium lepraemurium, 511
Mycobacterium microti, 510, 511
Mycobacteriumsp. strain Tarwin, 511
Mycobacterium tuberculosis, 510, 511, 515, 517
Mycobacterium visibile, 511
mycophenolate mofetil, 798
for epidermolysis bullosa acquisita, 197
for lupus erythematosus, 472
for pemphigus complex, 196
side effects, 198
mycoses
deep, 63,118,521–527
see alsofungal infections; onychomycosis
mycosis fungoidesseeepitheliotropic lymphoma
myiasis, 240
Myochrysineseegold sodium thiomalate
myringotomy,35,547, 562
myxedema, 418,425, 426–427
see alsohypothyroidism
myxedema coma, 422N-acetyl-L-cysteine (NAC), 151, 548, 550
naloxone, 798
naltrexone, 798
Naprosynseenaproxen
naproxen, 799
Narcanseenaloxone
nasal arteritis, 67,139,699, 706
nasal furunculosis, eosinophilic, 63, 115
nasal hypopigmentation, 65, 67
nasal parakeratosis, hereditary, of labradors, 62, 67,
103,432, 442
nasal planum
biopsy, 37
dermatoses, 67,137–141
nasal pyoderma, 67, 213
nasal solar dermatitis, 67, 138
nasodigital hyperkeratosis, idiopathic canine, 62, 67,
97,433–434, 446
Naxcelseeceftiofur
Naxenseenaproxen
Nebcinseetobramycin
necrolysis, 40
necrolytic migratory erythemaseesuperficial necrolytic
dermatosis
neomycin,269, 276, 799
neoplasia
claw/clawfold region, 66,136,592,603–604, 605
cutaneous lymphomaseeepitheliotropic lymphoma,
cutaneous
keratinization disorders, 435, 457
lymphomaseecutaneous nonepitheliotropic
lymphoma
mast cell tumors, 494–500
nodular, 69
onychomadesis, 591
panniculitis, 565
paraneoplastic syndromesseeparaneoplastic
dermatoses
paronychia, 590
pododermatitis, 590, 600
skin and adnexaseeskin and adnexal tumors
ultraviolet light induced, 575
see alsopreneoplastic dermatoses; tumors
Neoralseecyclosporine
Neosarseecyclophosphamide
neuro-immuno-cutaneous-endocrine (NICE)
model, 228
Neurontinseegabapentin
neutrophilic leukocytoclastic vasculitis of Jack Russell
terriers, 63, 699
nevus/nevi, 66, 131
see alsocollagenous nevi, multiple